Citadel Advisors
SANA icon

Citadel Advisors’s Sana Biotechnology SANA Stock Holding History

Citadel Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Sell
126,100
-81,800
-39% -$322K ﹤0.01% 10036
2025
Q4 		$846K Buy
207,900
+105,900
+104% +$474K ﹤0.01% 7783
2025
Q3 		$362K Sell
102,000
-80,900
-44% -$292K ﹤0.01% 9913
2025
Q2 		$499K Buy
182,900
+100
+0.1% +$206 ﹤0.01% 8633
2025
Q1 		$307K Buy
182,800
+113,700
+165% +$318K ﹤0.01% 9525
2024
Q4 		$113K Buy
69,100
+23,300
+51% +$69.5K ﹤0.01% 11290
2024
Q3 		$191K Sell
45,800
-55,000
-55% -$289K ﹤0.01% 10228
2024
Q2 		$550K Buy
100,800
+23,800
+31% +$190K ﹤0.01% 7858
2024
Q1 		$770K Buy
77,000
+48,200
+167% +$361K ﹤0.01% 7469
2023
Q4 		$118K Buy
28,800
+19,400
+206% +$71.5K ﹤0.01% 10734
2023
Q3 		$36.4K Sell
9,400
-86,500
-90% -$465K ﹤0.01% 12115
2023
Q2 		$572K Buy
95,900
+92,700
+2,897% +$534K ﹤0.01% 7648
2023
Q1 		$10.5K Buy
3,200
+2,400
+300% +$9.59K ﹤0.01% 13529
2022
Q4 		$3.16K Sell
800
-10,000
-93% -$48.9K ﹤0.01% 14244
2022
Q3 		$65K Sell
10,800
-17,000
-61% -$123K ﹤0.01% 11434
2022
Q2 		$179K Buy
+27,800
New +$177K ﹤0.01% 10815
2021
Q4 		– Sell
-24,100
Closed -$543K – 14633
2021
Q3 		$543K Buy
24,100
+7,300
+43% +$153K ﹤0.01% 9663
2021
Q2 		$330K Buy
+16,800
New +$381K ﹤0.01% 11037

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Citadel Advisors's SANA Position: Q1 2026 in Review

Citadel Advisors increased its Sana Biotechnology (SANA) stake by 4,103% in Q1 2026, buying an estimated $2.19M and bringing the position to 569,090 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #6533.

Citadel Advisors first reported a position in SANA in Q1 2021 and has held it in 20 quarters since. The position peaked at $23.3M in Q3 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Citadel Advisors held 569,090 shares of Sana Biotechnology worth $1.64M as of Q1 2026.
  • Citadel Advisors bought 555,549 Sana Biotechnology shares in Q1 2026, an estimated $2.19M.
  • Sana Biotechnology made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6533 holding.
  • Citadel Advisors first reported a position in Sana Biotechnology in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's Sana Biotechnology position peaked at $23.3M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.